A 55-year-old Caucasian man presented with unilateral right facial spider nevi. Relevant medical history included a right-sided cerebrovascular accident (CVA) in 1997 and decompensated alcoholic liver disease, diagnosed in 2007. The literature describes approximately 100 cases of unilateral spider nevi associated with different aetiologies, grouped under 'unilateral nevoid telangiectasia syndrome' (UNTS). This is a rare presentation of a commonly observed sign in clinical practice. This case offers an opportunity to explore the origins of spider nevi and highlights the benefit of sharing knowledge in order to help elucidate the potential mechanisms underlying common signs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4997/JRCPE.2013.306 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Real-World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid.
Pharmacoepidemiol Drug Saf
January 2025
Hunan Institute for Drug Control, Changsha, Hunan, China.
Background And Objectives: Based on the Adverse Event Reporting System (FAERS) data from the US FDA, this study mined the adverse drug reactions of obeticholic acid (OCA) in the real world and provided reference for clinical safe drug use.
Methods: Adverse event reports for OCA from the second quarter of 2016 to the third quarter of 2023 were extracted. The analysis for adverse reaction signal detection was conducted using reporting odds ratio, proportional reporting ratio, Bayesian confidence propagation neural network, and multi-item gamma Poisson shrinker methods.
Post-marketing safety surveillance of ado-trastuzumab emtansine: a real-world data retrospective cohort study using disproportionality analysis.
Expert Opin Drug Saf
December 2024
Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Article Synopsis
- Ado-trastuzumab emtansine (T-DM1) is used for treating HER2-positive breast cancer but has potential adverse events (AEs) that need careful evaluation.* -
- A comprehensive study analyzed 3,699 patient reports from 2013 to 2022, identifying new bleeding-related AEs and highlighting bleeding in the digestive, respiratory, and nervous systems.* -
- This analysis is the most thorough on T-DM1-induced hemorrhages, aiming to enhance understanding of these severe complications and guide future research.*
Spider angioma at the injection site of the meningitis vaccine.
Oxf Med Case Reports
February 2024
Department of Dermatology, Alassad Medical Centre, Hama, Syrian Arab Republic.
Spider angioma is a cutaneous nevus caused by a vascular abnormality, characterized by a central red area with radiating reddish, web-like extensions. It is typically associated with liver cirrhosis, hyperestrogenism, and alcohol consumption. In this case report, we present a unique instance of a patient who developed spider angioma at the injection site of the meningitis vaccine as a long-term adverse effect.
View Article and Find Full Text PDFColonic spider naevi in a middle-aged man.
Gut
February 2024
Department of Cellular Pathology, North Bristol NHS Trust, Bristol, UK
High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies: a pharmacovigilance study based on the FAERS database.
Expert Opin Drug Saf
November 2023
Department of Pharmacy, The First Affiliated Hospital of Army Medical University, Chongqing, China.
Background: T-DM1 and T-DXd are two promising antibody-drug conjugates for treating advanced HER2-positive breast cancer and HER2-mutated lung cancer. Understanding the differences in the adverse events (AEs) profile of both drugs may help clinicians make an appropriate treatment decision.
Research Design And Methods: All data obtained from the FDA Adverse Event Reporting System (FAERS) database from Q1 2004 to Q3 2022 underwent disproportionality analysis and Bayesian analysis to detect and assess the AE signals of T-DM1 and T-DXd for comparison.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!